← back to search

Thomas Wısnıewskı

New York University · US
Area of research
Physiology · Molecular Biology
Research interest
Research interests include Medicine, Alzheimer's disease, Disease, Neuroscience, Psychology, and Amyloid (mycology).
h-index
citations
12,961
works
112
NIH funding
primary concept
email

Recent publications

Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease
Nature Communications 2025cited by 9position: middledoi
Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease
Alzheimer s & Dementia 2025cited by 8position: middledoi
Valacyclovir Treatment of Early Symptomatic Alzheimer Disease
JAMA 2025cited by 6position: middledoi
Mitochondria in Alzheimer’s Disease Pathogenesis
Life 2024cited by 49position: middledoi
Similar brain proteomic signatures in Alzheimer’s disease and epilepsy
Acta Neuropathologica 2024cited by 35position: middledoi
Factors Affecting Resilience and Prevention of Alzheimer's Disease and Related Dementias
Annals of Neurology 2024cited by 28position: lastdoi
Choroid plexus aging: structural and vascular insights from the HCP-aging dataset
Fluids and Barriers of the CNS 2024cited by 28position: middledoi
The influence of APOEε4 on the pTau interactome in sporadic Alzheimer’s disease
Acta Neuropathologica 2024cited by 25position: lastdoi
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation
Acta Neuropathologica 2024cited by 22position: middledoi
Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment
Acta Neuropathologica 2024cited by 18position: lastdoi
Lewy pathology formation in patient-derived <i>GBA1</i> Parkinson’s disease midbrain organoids
Brain 2024cited by 16position: middledoi
Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder
Autism Research 2024cited by 15position: middledoi
Down Syndrome Biobank Consortium: A perspective
Alzheimer s & Dementia 2024cited by 15position: middledoi
Genome‐wide association studies identify novel loci in rapidly progressive Alzheimer's disease
Alzheimer s & Dementia 2024cited by 14position: middledoi
<scp>hnRNP A1</scp>, <scp>hnRNP A2B1</scp>, and <scp>hnRNP</scp> K are dysregulated in tauopathies, but do not colocalize with tau pathology
Brain Pathology 2024cited by 14position: middledoi
X‐chromosome-wide association study for Alzheimer’s disease
Molecular Psychiatry 2024cited by 6position: middledoi
Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer's disease, and primary age‐related tauopathy hippocampi
Alzheimer s & Dementia 2024cited by 5position: middledoi
Compilation of reported protein changes in the brain in Alzheimer’s disease
Nature Communications 2023cited by 169position: middledoi
Spatial proteomics of hippocampal subfield‐specific pathology in Alzheimer's disease and primary age‐related tauopathy
Alzheimer s & Dementia 2023cited by 38position: middledoi
FDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness
Alzheimer s & Dementia 2023cited by 38position: middledoi
Neuropsychological test performance of former American football players
Alzheimer s Research & Therapy 2023cited by 33position: middledoi
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome
Alzheimer s & Dementia 2023cited by 30position: middledoi
Are brief febrile seizures benign? A systematic review and narrative synthesis
Epilepsia 2023cited by 21position: middledoi
Metabolomic, proteomic, and transcriptomic changes in adults with epilepsy on modified Atkins diet
Epilepsia 2023cited by 17position: middledoi
Identifying healthy individuals with Alzheimer’s disease neuroimaging phenotypes in the UK Biobank
Communications Medicine 2023cited by 15position: middledoi
Localized proteomic differences in the choroid plexus of Alzheimer's disease and epilepsy patients
Frontiers in Neurology 2023cited by 14position: lastdoi
LATE-NC staging in routine neuropathologic diagnosis: an update
Acta Neuropathologica 2022cited by 172position: middledoi
The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
Acta Neuropathologica Communications 2022cited by 149position: lastdoi
Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19
Neurology 2022cited by 58position: middledoi
Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observational study
PLoS ONE 2022cited by 51position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eleanor Drummond · The University of Sydney20 papers (2015–2024)Beatrix Ueberheide · NYU Langone Health15 papers (2015–2024)Geoffrey Pires · New York University11 papers (2017–2024)Dominique Leitner · New York University11 papers (2021–2024)Evgeny Kanshin · New York University10 papers (2021–2024)Manor Askenazi · New York University9 papers (2017–2024)Orrin Devinsky · University of California, Davis9 papers (2018–2024) · 9 papers (2012–2024)Pankaj Mehta · Boston University8 papers (2012–2020)Daniel Friedman · King's College London7 papers (2018–2023) · 7 papers (2012–2015) · 7 papers (2012–2015)Mony J. de Leon · Cornell University7 papers (2012–2022)Shruti Nayak · New York University7 papers (2015–2022)Jarek Wegiel · New York University7 papers (2012–2024)Arline Faustin · New York University7 papers (2016–2024)Krzysztof Nowicki · California Institute for Regenerative Medicine7 papers (2012–2015) · 7 papers (2012–2015)Yanjie Sun · North West Agriculture and Forestry University7 papers (2012–2017) · 7 papers (2012–2015)